Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells

By Xu Qin   Ohara Noriyuki   Chen Wei   Liu Jin   Sasaki Hiroko   Morikawa Akira   Sitruk-Ware Regine   Johansson Elof D.B.   Maruo Takeshi  

Human Reproduction, Vol. 21, Iss. 9, 2006-09 ,pp. : 2408-2416

Oxford University Press

Access to resources Recommend Favorite

Progesterone down‐regulates insulin‐like growth factor‐I expression in cultured human uterine leiomyoma cells

By Yamada Takashi   Nakago Satoshi   Kurachi Osamu   Wang Jiayin   Takekida Shigeki   Matsuo Hiroya   Maruo Takeshi  

Human Reproduction, Vol. 19, Iss. 4, 2004-04 ,pp. : 815-821

Oxford University Press

Access to resources Recommend Favorite

The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women

By Chwalisz Kristof  

Human Reproduction, Vol. 20, Iss. 4, 2005-04 ,pp. : 1090-1099

Oxford University Press

Access to resources Recommend Favorite

The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata

By Williams A.R.W.   Critchley H.O.D.   Osei J.   Ingamells S.   Cameron I.T.   Han C.   Chwalisz K.  

Human Reproduction, Vol. 22, Iss. 6, 2007-06 ,pp. : 1696-1704

Oxford University Press

Access to resources Recommend Favorite

Progesterone and progesterone receptor modulator in uterine leiomyoma growth

By Maruo Takeshi  

Gynecological Endocrinology, Vol. 23, Iss. 4, 2007-04 ,pp. : 186-187

Informa Healthcare

Access to resources Recommend Favorite